End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.05 USD | +1.00% | -.--% | -.--% |
Valuation
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Capitalization 1 | 21.5 | 22.49 | 3.283 | 3.173 |
Enterprise Value (EV) 1 | 21.5 | 24.29 | 3.283 | 3.173 |
P/E ratio | -0.27 x | - | -0.1 x | - |
Yield | - | - | - | - |
Capitalization / Revenue | - | 4.45 x | - | 0.16 x |
EV / Revenue | - | 4.45 x | - | 0.16 x |
EV / EBITDA | - | -2,269,717 x | - | - |
EV / FCF | - | - | - | - |
FCF Yield | - | - | - | - |
Price to Book | - | - | - | - |
Nbr of stocks (in thousands) | 267 | 385 | 1,001 | 264,417 |
Reference price 2 | 80.50 | 58.45 | 3.280 | 0.0120 |
Announcement Date | 22/04/21 | 29/04/22 | 16/05/23 | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Net sales 1 | - | 5.058 | - | 20.4 |
EBITDA | - | -9.907 | - | - |
EBIT | - | -11.27 | - | - |
Operating Margin | - | -222.8% | - | - |
Earnings before Tax (EBT) 1 | - | - | - | -3.6 |
Net income 1 | -12.69 | - | -13.52 | -3.6 |
Net margin | - | - | - | -17.65% |
EPS | -297.5 | - | -34.17 | - |
Free Cash Flow | - | - | - | - |
FCF margin | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - |
Dividend per Share | - | - | - | - |
Announcement Date | 22/04/21 | 29/04/22 | 16/05/23 | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 S1 |
---|---|
Net sales | - |
EBITDA | - |
EBIT | - |
Operating Margin | - |
Earnings before Tax (EBT) | - |
Net income 1 | -4.694 |
Net margin | - |
EPS 2 | -17.85 |
Dividend per Share | - |
Announcement Date | 15/09/21 |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Net Debt | - | 1.81 | - | - |
Net Cash position | - | - | - | - |
Leverage (Debt/EBITDA) | - | -0.1825 x | - | - |
Free Cash Flow | - | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - |
Assets 1 | - | - | - | - |
Book Value Per Share | - | - | - | - |
Cash Flow per Share | - | - | - | - |
Capex | - | - | - | - |
Capex / Sales | - | - | - | - |
Announcement Date | 22/04/21 | 29/04/22 | 16/05/23 | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- GMVDF Stock
- GMMVD Stock
- Financials G Medical Innovations Holdings Ltd